Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MYNZ
MYNZ logo

MYNZ News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MYNZ News

Mainz Biomed to Present at Digestive Disease Week 2026

Feb 24 2026Newsfilter

Mainz Biomed Secures $6 Million Financing for Strategic Shift

Feb 17 2026seekingalpha

Mainz Biomed Secures $6 Million Funding to Enhance Liquidity and Focus on Pancreatic Cancer Detection

Feb 17 2026Newsfilter

Mainz Biomed Launches eAArly DETECT 2 Clinical Study Covering 2,000 Patients

Jan 05 2026Globenewswire

Mainz Biomed Integrates ColoAlert® Test into DoctorBox Platform in Germany

Dec 02 2025Globenewswire

Mainz Biomed Partners with DoctorBox to Launch ColoAlert Test in Germany

Dec 02 2025Newsfilter

Mainz Biomed and OncoVanguard8 Partner to Introduce ColoAlert in South America

Nov 18 2025Newsfilter

Mainz Biomed to Showcase ColoAlert, Its Leading Product, at MEDICA 2025

Nov 12 2025NASDAQ.COM

MYNZ Events

03/13 07:40
Mainz Biomed Renames to Quantum Cyber, Changes Ticker to QUCY
Mainz Biomed, doing business as Quantum Cyber, announced, effective upon the commencement of trading on March 12, it officially changed its ticker symbol to "QUCY" on the Nasdaq Capital Market. Further the Company's name will change to Quantum Cyber effective with a general meeting of shareholders planned for April 2026. The corporate name change and stock ticker symbol change reflect the Company's business strategy and better reflect the future operations, which will include a shift toward quantum computing and cybersecurity-oriented offerings.
03/11 07:40
Mainz Biomed Appoints Robert Liscouski as Chairman and Renames to Quantum Cyber
Mainz Biomed announced that Robert Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Liscouski and the change of Company name will become effective at the Company's extraordinary general meeting, being planned for April 2026. The Company will begin doing business as Quantum Cyber and trading under the symbol QUCY beginning on March 12, 2026.

MYNZ Monitor News

Mainz Biomed NV stock surges amid market weakness

Mar 11 2026

Mainz Biomed NV stock rises amid sector rotation

Feb 17 2026

Mainz Biomed NV stock rises amid market gains

Jan 26 2026

MYNZ Earnings Analysis

No Data

No Data

People Also Watch